Globalization and Innovation in the Indian Pharmaceutical Industry

Bishwanjit Loitongbam (bishanjit99@gmail.com)

MPRA Paper from University Library of Munich, Germany

Abstract: The changing global environment brings about new opportunities and new markets for domestic firms in developing countries. We examine the impacts of globalization and IPR protection on the innovation in the Indian pharmaceutical industry, using the firm-level panel data. This paper finds that there is a positive and highly significant level of foreign ownership effect on R&D activities. This indicates that there is technology spillover in the Indian pharmaceutical industry. TRIPS implementation has insignificant effects on R&D innovation. It is also found that exporting firms and firms with a higher productivity level are significantly more likely to carry out R&D activities.

Keywords: Globalization; Foreign Ownership; Innovation; R&D (search for similar items in EconPapers)
JEL-codes: F1 F14 F6 (search for similar items in EconPapers)
Date: 2016-03-07, Revised 2016-05-27
New Economics Papers: this item is included in nep-bec, nep-cse, nep-ino, nep-int and nep-sbm
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/75925/1/MPRA_paper_75925.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:75925

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter (winter@lmu.de).